Arteriovenous Sheath Tunneler Set and Sterilization Cassette Information For Use

68 Pages

File Type: PDF

File Size: 403 KB

File Name: BARD - BAED - PK1136700 - Arteriovenous Sheath Tunneler Set and Sterilization Cassette Information For Use - 2014-08 - Rev 3.pdf

Preview

Page 1

Arteriovenous (AV) Sheath Tunneler Set and Sterilization Cassette INFORMATION FOR USE Indication The Arteriovenous Sheath Tunneler (AV Sheath Tunneler) is intended to aid in creating subcutaneous tunnels for the placement of vascular prostheses (grafts) for arteriovenous access procedures. The Tunneler will facilitate the placement of externally supported grafts up to 7mm I.D. A Tunneler Sterilization Cassette is provided to hold and protect the Tunneler components when not in use and to allow penetration of steam during sterilization. The Cassette is to be used with an appropriate sterilization wrap. Description The AV Sheath Tunneler consists of four components, that when assembled create a single unit device. The Tunneler components include the Handle, Inner Rod, Outer Sheath, and Tip (reference Figure 1). Figure 1 Handle

Outer Sheath Inner Rod

Tip

Both the Tunneler and the Tunneler Sterilization Cassette are reusable medical devices. The Tunneler components are made of medical grade stainless steel. The Tunneler Sterilization Cassette is composed of Radel™ R (polyphenylsulfone) and has four medical grade stainless steel latches. These materials are designed to withstand repeated use, cleaning, and resterilization. Precautions 1. Prior to utilizing the AV Sheath Tunneler, verify that the vascular graft outside diameter fits within the Sheath and the graft length is longer than the tissue tunnel to be created. Failure to do so may make it difficult to achieve optimal graft placement. 2. Care should be exercised to protect the Tunneler from mechanical damage. Rough handling may mar the surface of the Tunneler. 3. Do not soak Tunneler components in saline or bleach solutions. Doing so could cause damage to component surfaces. 4. The Tunneler is supplied non-sterile and must be thoroughly cleaned and sterilized prior to each use. Cleaning / sterilization of the Tunneler prior to use is the responsibility of the healthcare facility. Cleaning Prior To Sterilization Personnel should wear appropriate protective attire when handling the AV Sheath Tunneler components and the Tunneler Sterilization Cassette. Immediately after use, completely disassemble the Tunneler and rinse the components and the Tunneler Sterilization Cassette in cool running tap water, utilizing brushing if needed, to aid in the removal of visible debris. Use appropriate brushes that are compatible with stainless steel surgical instruments. A mechanical cleaning system or manual cleaning method may be used to clean the Tunneler components and the Tunneler Sterilization Cassette. Consult the mechanical cleaning system and cleaning agent manufacturer’s instructions for cleaning surgical instruments. The following manual cleaning method is suggested: 1. Use appropriate brushes that are compatible with stainless steel surgical instruments to aid in cleaning the inner lumen of the Sheath and crevices on the threaded portions of the Rod, Tip, and Handle. Remove all particles of adhering tissue and dried blood from the Tunneler Sterilization Cassette and the disassembled Tunneler components using cool running tap water, scrubbing with appropriate brushes to aid in cleaning the inner lumen of the Sheath and crevices on the threaded portions of the Rod, Tip, and Handle. The Tunneler components and Cassette should then be soaked in water and mild, enzymatic detergent. Prepare the enzymatic detergent solution per the detergent manufacturer’s instructions. Soak the Tunneler components and Cassette for ten minutes. Rinse the Tunneler components and the Tunneler Sterilization Cassette in distilled water to remove all traces of detergents and debris. (1)

ENGLISH

Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.

2. Place disassembled Tunneler components into an ultrasonic cleaning device with freshly prepared enzymatic detergent per manufacturer’s instructions, for a minimum of 15 minutes. NOTE: If an ultrasonic cleaning device is not available, continue to soak/clean in enzymatic detergent for a minimum of 30 minutes. 3. Rinse the Tunneler components and the Tunneler Sterilization Cassette in distilled water to remove all traces of detergents and debris. Allow all Tunneler components and the Tunneler Sterilization Cassette to air dry. 4. It is important to inspect all Tunneler components and the Tunneler Sterilization Cassette to insure that they are clean and free of damage prior to sterilization. Damage that could prevent proper function of the Tunneler includes scratches, cross-threading, etching, pitting, burrs, nicks, dents or cracks. For proper use, the Tunneler Sterilization Cassette should latch when closed and should be free of any structural damage. Reference Precautions #2, #3 and #4. Sterilization After cleaning and inspection, all disassembled AV Sheath Tunneler components should be placed in the Tunneler Sterilization Cassette. Prior to use, the Tunneler Sterilization Cassette must be enclosed in an appropriate commercialized sterilization wrap used in accordance with the wrap manufacturer’s instructions. Warning: Do not stack Tunneler Sterilization Cassettes during sterilization period. Sterilize the Tunneler using the preferred cycle parameters: Using a gravity displacement steam sterilizer: Temperature: at or above 250°F (121°C) Exposure Time: 30 minutes Drying Time: 45 minutes Temperature: at or above 270°F (132°C) Exposure Time: 15 minutes Drying Time: 45 minutes Using a pre-vacuum (high vacuum) steam sterilizer: Temperature: at or above 270°F (132°C) Exposure Time: 3 minutes Drying Time: 45 minutes Prior to opening the sterilization wrap, inspect the wrap for tears, pinholes, or other damage that might compromise sterility. The Cassette must be enclosed in an appropriate commercially available sterilization wrap in order to preserve sterility after processing. Using the Tunneler 1. Remove the sterile AV Sheath Tunneler components from the Tunneler Sterilization Cassette using appropriate aseptic technique. 2. To assemble the sterile Tunneler components: Thread and hand tighten the Tip to either end of the selected Rod. Slide Sheath over Rod so that the exposed threaded end of the Rod extends beyond the Sheath end. Carefully secure (thread) the Handle onto the exposed fully threaded end of the Rod. Hand-tighten the assembly, making sure that the shoulders of the Tip and Handle are snug against the ends of the Sheath. 3. Follow standard surgical practice to create entrance and exit incisions for the Tunneler. 4. Use the sterile assembled Tunneler to create a tissue tunnel connecting the entrance and exit incisions. 5. When the Tunneler passes through the exit incision site and a satisfactory tunnel has been created, unscrew the Handle 1/2 turn, and then completely remove the Tip from the Rod. 6. When tunneling is completed and the Tip will not be needed for the remainder of the procedure, remove the Tip from the surgical field and return it to the Tunneler Sterilization Cassette. Positioning the AV Graft Option 1: After ensuring Sheath position is optimum, remove Rod and Handle assembly, leaving the Sheath in place. Feed graft into Sheath using a gentle pushing method. Do not twist the graft. Visualize the orientation line to verify accurate placement. When graft has been pushed into position within the Sheath, hold graft at the exit incision site, grasp the protruding Sheath end and carefully pull (remove) the Sheath from the tissue tunnel, leaving the graft properly placed inside the tissue tunnel.

(2)

Reference Precaution #1. Option 2: Secure (tie) the graft onto the Rod by placing a suture through the tapered hole at the exposed end of the Rod. Verify that the vascular graft outside diameter fits within the Sheath and the graft length is longer than the tissue tunnel. Carefully pull the graft through the Sheath, using the Handle and Rod assembly. When the graft has been pulled into position within the Sheath, release it from the Rod by cutting the suture. While holding the graft at the exit incision site, grasp the protruding Sheath end and carefully pull (remove) the Sheath from the tissue tunnel, leaving the graft properly placed inside the tissue tunnel. Proceed with the vascular anastomoses. Reference Precaution #1. Maintenance Procedures Proper maintenance of the AV Sheath Tunneler requires careful handling and inspection of each Tunneler component and the Tunneler Sterilization Cassette. Particular care should be taken to avoid damaging the threaded portions of the Rod, Handle, and Tip. If these areas are damaged through improper handling (i.e., dropping, cross-threading, brushing and/or cleaning with abrasives) the parts may not fit together properly. Do not use the Tunneler if such damage occurs. Contact Bard Peripheral Vascular for appropriate replacement parts and ordering information. Warranty Bard Peripheral Vascular, Inc. warrants to the first purchaser of this product that this product will be free from defects in materials and workmanship for a period of one year from the date of first purchase and liability under this limited product warranty will be limited to repair or replacement of the defective product, in Bard Peripheral Vascular’s sole discretion or refunding your net price paid. Wear and tear from normal use or defects resulting from misuse of this product are not covered by this limited warranty. TO THE EXTENT ALLOWABLE BY APPLICABLE LAW, THIS LIMITED PRODUCT WARRANTY IS IN LIEU OF ALL OTHER WARRANTIES, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT WILL BARD PERIPHERAL VASCULAR BE LIABLE TO YOU FOR ANY INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES RESULTING FROM YOUR HANDLING OR USE OF THIS PRODUCT. Some states/countries do not allow an exclusion of implied warranties, incidental or consequential damages. You may be entitled to additional remedies under the laws of your state/country. An issue or revision date and a revision number for these instructions are included for the user's information on the last page of this booklet. In the event 36 months have elapsed between this date and product use, the user should contact Bard Peripheral Vascular Inc. to see if additional product information is available.

(3)

ǼȁȁǾȃǿȀǹ

ȈİĲİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢȝİĮȡĲȘȡȚȠĳȜİȕȚțȩșȘțȐȡȚțĮȚțĮıȑĲĮĮʌȠıĲİȓȡȦıȘȢ ȆȡȠıȠȤȒǾRȝȠıʌȠȞįȚĮțȒȞȠȝȠșİıȓĮ ĲȦȞǾȆǹ ʌİȡȚȠȡȓȗİȚĲȘȞʌȫȜȘıȘĲȘȢıȣıțİȣȒȢĮȣĲȒȢıİȚĮĲȡȠȪȢȒțĮĲȩʌȚȞİȞĲȠȜȒȢȚĮĲȡȠȪ ȆȁǾȇȅĭȅȇǿǼȈȋȇǾȈǾȈ ǲȞįİȚȟȘ ȉȠİȡȖĮȜİȓȠįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢȝİĮȡĲȘȡȚȠĳȜİȕȚțȩșȘțȐȡȚʌȡȠȠȡȓȗİĲĮȚȖȚĮȤȡȒıȘȦȢȕȠȒșȘȝĮıĲȘįȘȝȚȠȣȡȖȓĮȣʌȠįȩȡȚĮȢıȒȡĮȖȖĮȢȖȚĮ ĲȘȞĲȠʌȠșȑĲȘıȘĮȖȖİȚĮțȫȞʌȡȠșȑıİȦȞ ȝȠıȤİȣȝȐĲȦȞ ıİįȚĮįȚțĮıȓİȢĮȡĲȘȡȚȠĳȜİȕȚțȒȢʌȡȠıʌȑȜĮıȘȢȉȠİȡȖĮȜİȓȠįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢ įȚİȣțȠȜȪȞİȚĲȘȞĲȠʌȠșȑĲȘıȘİȟȦĲİȡȚțȐȣʌȠıĲȘȡȚȗȩȝİȞȦȞȝȠıȤİȣȝȐĲȦȞȝİİıȦĲİȡȚțȒįȚȐȝİĲȡȠȑȦȢțĮȚPPǻȚĮĲȓșİĲĮȚİʌȓıȘȢȝȓĮ țĮıȑĲĮĮʌȠıĲİȓȡȦıȘȢĲȠȣİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢȘȠʌȠȓĮĳȣȜȐııİȚțĮȚʌȡȠıĲĮĲİȪİȚĲĮİȟĮȡĲȒȝĮĲĮĲȠȣİȡȖĮȜİȓȠȣȩĲĮȞįİȞ ȤȡȘıȚȝȠʌȠȚȠȪȞĲĮȚțĮȚİʌȚĲȡȑʌİȚĲȘįȚİȓıįȣıȘĮĲȝȠȪțĮĲȐĲȘįȚȐȡțİȚĮĲȘȢĮʌȠıĲİȓȡȦıȘȢǾțĮıȑĲĮʌȡȑʌİȚȞĮȤȡȘıȚȝȠʌȠȚİȓĲĮȚıİ ıȣȞįȣĮıȝȩȝİțĮĲȐȜȜȘȜȠʌİȡȚĲȪȜȚȖȝĮĮʌȠıĲİȓȡȦıȘȢ ȆİȡȚȖȡĮĳȒ ȉȠİȡȖĮȜİȓȠįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢȝİĮȡĲȘȡȚȠĳȜİȕȚțȩșȘțȐȡȚĮʌȠĲİȜİȓĲĮȚĮʌȩĲȑııİȡĮİȟĮȡĲȒȝĮĲĮĲĮȠʌȠȓĮȩĲĮȞıȣȞĮȡȝȠȜȠȖȘșȠȪȞ ıȤȘȝĮĲȓȗȠȣȞȝȚĮİȞȚĮȓĮįȚȐĲĮȟȘȈĲĮİȟĮȡĲȒȝĮĲĮĲȠȣİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢʌİȡȚȜĮȝȕȐȞȠȞĲĮȚȘȜĮȕȒȘİıȦĲİȡȚțȒȡȐȕįȠȢĲȠ İȟȦĲİȡȚțȩșȘțȐȡȚțĮȚĲȠȐțȡȠ ĮȞĮĲȡȑȟĲİıĲȘȞİȚțȩȞĮ ǼȚțȩȞĮ İȟȦĲİȡȚțȩșȘțȐȡȚțĮȚ ȁĮȕȒ İıȦĲİȡȚțȒ ȐțȡȠ ȡȐȕįȠȢ

ȉȩıȠĲȠİȡȖĮȜİȓȠįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢȩıȠțĮȚȘțĮıȑĲĮĮʌȠıĲİȓȡȦıȒȢĲȠȣİȓȞĮȚİʌĮȞĮȤȡȘıȚȝȠʌȠȚȒıȚȝİȢȚĮĲȡȚțȑȢıȣıțİȣȑȢȉĮ İȟĮȡĲȒȝĮĲĮĲȠȣİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢİȓȞĮȚțĮĲĮıțİȣĮıȝȑȞĮĮʌȩĮȞȠȟİȓįȦĲȠȤȐȜȣȕĮȚĮĲȡȚțȠȪĲȪʌȠȣǾțĮıȑĲĮĮʌȠıĲİȓȡȦıȘȢ ĲȠȣİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢİȓȞĮȚțĮĲĮıțİȣĮıȝȑȞȘĮʌȩ5DGHO5 ʌȠȜȣĳĮȚȞȣȜȠıȠȣȜĳȩȞȘ țĮȚĳȑȡİȚĲȑııİȡȚȢĮıĳȐȜİȚİȢĮʌȩ ĮȞȠȟİȓįȦĲȠȤȐȜȣȕĮȚĮĲȡȚțȠȪĲȪʌȠȣȉĮȣȜȚțȐĮȣĲȐİȓȞĮȚıȤİįȚĮıȝȑȞĮȖȚĮȞĮĮȞĲȑȤȠȣȞıİİʌĮȞİȚȜȘȝȝȑȞȘȤȡȒıȘțĮșĮȡȚıȝȩțĮȚ İʌĮȞĮʌȠıĲİȓȡȦıȘ ȆȡȠĳȣȜȐȟİȚȢ ȆȡȠĲȠȪȤȡȘıȚȝȠʌȠȚȒıİĲİĲȠİȡȖĮȜİȓȠįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢȝİĮȡĲȘȡȚȠĳȜİȕȚțȩșȘțȐȡȚȕİȕĮȚȦșİȓĲİȩĲȚȘİȟȦĲİȡȚțȒįȚȐȝİĲȡȠȢĲȠȣ ĮȖȖİȚĮțȠȪȝȠıȤİȪȝĮĲȠȢİĳĮȡȝȩȗİȚȝȑıĮıĲȠșȘțȐȡȚțĮȚȩĲȚĲȠȝȒțȠȢĲȠȣȝȠıȤİȪȝĮĲȠȢİȓȞĮȚȝİȖĮȜȪĲİȡȠĮʌȩĲȘıȒȡĮȖȖĮʌȠȣșĮ ıȤȘȝĮĲȚıĲİȓıĲȠȞȚıĲȩǻȚĮĳȠȡİĲȚțȐșĮİȓȞĮȚįȪıțȠȜȠȞĮİʌȚĲİȣȤșİȓȘȚįĮȞȚțȒĲȠʌȠșȑĲȘıȘĲȠȣȝȠıȤİȪȝĮĲȠȢ ǹʌĮȚĲİȓĲĮȚʌȡȠıȠȤȒȫıĲİĲȠİȡȖĮȜİȓȠįȚȐȞȠȚȟȘȢȞĮʌȡȠıĲĮĲİȪİĲĮȚĮʌȩȝȘȤĮȞȚțȑȢȕȜȐȕİȢȅĲȡĮȤȪȢȤİȚȡȚıȝȩȢİȞįȑȤİĲĮȚȞĮĳșİȓȡİȚ ĲȘȞİʌȚĳȐȞİȚĮĲȠȣİȡȖĮȜİȓȠȣ ȂȘȞİȝȕȣșȓȗİĲİĲĮİȟĮȡĲȒȝĮĲĮĲȠȣİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢıİĳȣıȚȠȜȠȖȚțȩȠȡȩȒįȚĮȜȪȝĮĲĮȤȜȦȡȓȞȘȢȀȐĲȚĲȑĲȠȚȠșĮ ȝʌȠȡȠȪıİȞĮʌȡȠțĮȜȑıİȚȗȘȝȚȐıĲȚȢİʌȚĳȐȞİȚİȢĲȦȞİȟĮȡĲȘȝȐĲȦȞ ȉȠİȡȖĮȜİȓȠįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢʌĮȡȑȤİĲĮȚȝȘıĲİȓȡȠțĮȚșĮʌȡȑʌİȚȞĮțĮșĮȡȓȗİĲĮȚıȤȠȜĮıĲȚțȐțĮȚȞĮĮʌȠıĲİȚȡȫȞİĲĮȚʌȡȚȞĮʌȩțȐșİ ȤȡȒıȘȅțĮșĮȡȚıȝȩȢțĮȚȘĮʌȠıĲİȓȡȦıȘĲȠȣİȡȖĮȜİȓȠȣʌȡȚȞĮʌȩĲȘȤȡȒıȘĮʌȠĲİȜİȓİȣșȪȞȘĲȠȣȚįȡȪȝĮĲȠȢʌİȡȓșĮȜȥȘȢ ȀĮșĮȡȚıȝȩȢʌȡȚȞĮʌȩĲȘȞĮʌȠıĲİȓȡȦıȘ ȉȠʌȡȠıȦʌȚțȩșĮʌȡȑʌİȚȞĮĳȠȡȐțĮĲȐȜȜȘȜȘʌȡȠıĲĮĲİȣĲȚțȒʌİȡȚȕȠȜȒțĮĲȐĲȠȤİȚȡȚıȝȩĲȦȞİȟĮȡĲȘȝȐĲȦȞĲȠȣİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢ ıȒȡĮȖȖĮȢȝİĮȡĲȘȡȚȠĳȜİȕȚțȩșȘțȐȡȚțĮȚĲȘȢțĮıȑĲĮȢĮʌȠıĲİȓȡȦıȘȢĲȠȣİȡȖĮȜİȓȠȣǹȝȑıȦȢȝİĲȐĲȘȤȡȒıȘĮʌȠıȣȞĮȡȝȠȜȠȖȒıĲİʌȜȒȡȦȢ ĲȠİȡȖĮȜİȓȠįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢțĮȚİțʌȜȪȞİĲİĲĮİȟĮȡĲȒȝĮĲĮțĮȚĲȘȞțĮıȑĲĮĮʌȠıĲİȓȡȦıȘȢĲȠȣİȡȖĮȜİȓȠȣıİțȡȪȠĲȡİȤȠȪȝİȞȠȞİȡȩ ȕȡȪıȘȢȤȡȘıȚȝȠʌȠȚȫȞĲĮȢȕȠȪȡĲıĮİȐȞİȓȞĮȚĮʌĮȡĮȓĲȘĲȠʌȡȠțİȚȝȑȞȠȣȞĮĮʌȠȝĮțȡȣȞșȠȪȞĲĮȠȡĮĲȐȣʌȠȜİȓȝȝĮĲĮȋȡȘıȚȝȠʌȠȚȒıĲİ ȕȠȪȡĲıİȢțĮĲȐȜȜȘȜİȢȖȚĮȤİȚȡȠȣȡȖȚțȐİȡȖĮȜİȓĮĮʌȩĮȞȠȟİȓįȦĲȠȤȐȜȣȕĮīȚĮȞĮțĮșĮȡȓıİĲİĲĮİȟĮȡĲȒȝĮĲĮțĮȚĲȘȞțĮıȑĲĮĮʌȠıĲİȓȡȦıȘȢ ĲȠȣİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢȝʌȠȡİȓĲİȞĮȤȡȘıȚȝȠʌȠȚȒıİĲİțȐʌȠȚȠȝȘȤĮȞȚțȩıȪıĲȘȝĮțĮșĮȡȚıȝȠȪȒțȐʌȠȚĮȝȑșȠįȠțĮșĮȡȚıȝȠȪ įȚĮȤİȚȡȩȢȈȣȝȕȠȣȜİȣĲİȓĲİĲȚȢȠįȘȖȓİȢȖȚĮĲȠȞțĮșĮȡȚıȝȩȤİȚȡȠȣȡȖȚțȫȞİȡȖĮȜİȓȦȞĲȠȣțĮĲĮıțİȣĮıĲȒĲȠȣıȣıĲȒȝĮĲȠȢȝȘȤĮȞȚțȠȪ țĮșĮȡȚıȝȠȪțĮȚĲȠȣțĮĲĮıțİȣĮıĲȒĲȠȣțĮșĮȡȚıĲȚțȠȪȝȑıȠȣ ȈȣȞȚıĲȐĲĮȚȘʌĮȡĮțȐĲȦȝȑșȠįȠȢțĮșĮȡȚıȝȠȪįȚĮȤİȚȡȩȢ īȚĮĲȠȞțĮșĮȡȚıȝȩĲȠȣİıȦĲİȡȚțȠȪĮȣȜȠȪĲȠȣșȘțĮȡȚȠȪțĮȚĲȦȞİıȠȤȫȞĲȦȞĲȝȘȝȐĲȦȞĲȘȢȡȐȕįȠȣĲȠȣȐțȡȠȣțĮȚĲȘȢȜĮȕȒȢʌȠȣ ĳȑȡȠȣȞıʌİȓȡȦȝĮȤȡȘıȚȝȠʌȠȚȒıĲİȕȠȪȡĲıİȢțĮĲȐȜȜȘȜİȢȖȚĮȤİȚȡȠȣȡȖȚțȐİȡȖĮȜİȓĮĮʌȩĮȞȠȟİȓįȦĲȠȤȐȜȣȕĮǹĳĮȚȡȑıĲİȩȜĮĲĮ ȣʌȠȜİȓȝȝĮĲĮʌȡȠıțȠȜȜȘȝȑȞȠȣȚıĲȠȪțĮȚȟȘȡĮȝȑȞȠȣĮȓȝĮĲȠȢĮʌȩĲȘȞțĮıȑĲĮĮʌȠıĲİȓȡȦıȘȢțĮȚĲĮĮʌȠıȣȞĮȡȝȠȜȠȖȘȝȑȞĮİȟĮȡĲȒȝĮĲĮ ĲȠȣİȡȖĮȜİȓȠȣıȘȡĮȖȖȠʌȠȓȘıȘȢȤȡȘıȚȝȠʌȠȚȫȞĲĮȢțȡȪȠĲȡİȤȠȪȝİȞȠȞİȡȩȕȡȪıȘȢțĮȚĲȡȓȕȠȞĲĮȢȝİțĮĲȐȜȜȘȜİȢȕȠȪȡĲıİȢȖȚĮĲȠȞ țĮșĮȡȚıȝȩĲȠȣİıȦĲİȡȚțȠȪĮȣȜȠȪĲȠȣșȘțĮȡȚȠȪțĮȚĲȦȞİıȠȤȫȞĲȦȞĲȝȘȝȐĲȦȞĲȘȢȡȐȕįȠȣĲȠȣȐțȡȠȣțĮȚĲȘȢȜĮȕȒȢʌȠȣĳȑȡȠȣȞ (22)

ıʌİȓȡȦȝĮȉĮİȟĮȡĲȒȝĮĲĮĲȠȣİȡȖĮȜİȓȠȣıȘȡĮȖȖȠʌȠȓȘıȘȢțĮȚȘțĮıȑĲĮșĮʌȡȑʌİȚıĲȘıȣȞȑȤİȚĮȞĮİȝȕȣșȚıĲȠȪȞıİȞİȡȩȝİȒʌȚȠ İȞȗȣȝȚțȩțĮșĮȡȚıĲȚțȩȆȡȠİĲȠȚȝȐıĲİĲȠįȚȐȜȣȝĮĲȠȣİȞȗȣȝȚțȠȪțĮșĮȡȚıĲȚțȠȪıȪȝĳȦȞĮȝİĲȚȢȠįȘȖȓİȢĲȠȣțĮĲĮıțİȣĮıĲȒǼȝȕȣșȓıĲİ ĲĮİȟĮȡĲȒȝĮĲĮĲȠȣİȡȖĮȜİȓȠȣıȘȡĮȖȖȠʌȠȓȘıȘȢțĮȚĲȘȞțĮıȑĲĮİʌȓįȑțĮȜİʌĲȐǼțʌȜȪȞİĲİȝİĮʌİıĲĮȖȝȑȞȠȞİȡȩĲĮİȟĮȡĲȒȝĮĲĮĲȠȣ İȡȖĮȜİȓȠȣıȘȡĮȖȖȠʌȠȓȘıȘȢțĮȚĲȘȞțĮıȑĲĮĮʌȠıĲİȓȡȦıȘȢĲȠȣİȡȖĮȜİȓȠȣıȘȡĮȖȖȠʌȠȓȘıȘȢȖȚĮȞĮĮʌȠȝĮțȡȪȞİĲİțȐșİȓȤȞȠȢ ĮʌȠȡȡȣʌĮȞĲȚțȠȪțĮȚȣʌȠȜİȚȝȝȐĲȦȞ ȉȠʌȠșİĲȒıĲİĲĮĮʌȠıȣȞĮȡȝȠȜȠȖȘȝȑȞĮİȟĮȡĲȒȝĮĲĮĲȠȣİȡȖĮȜİȓȠȣıȘȡĮȖȖȠʌȠȓȘıȘȢȝȑıĮıİıȣıțİȣȒțĮșĮȡȚıȝȠȪȝİȣʌİȡȒȤȠȣȢİʌȓ ȜİʌĲȐĲȠȣȜȐȤȚıĲȠȞȝĮȗȓȝİİȞȗȣȝȚțȩĮʌȠȡȡȣʌĮȞĲȚțȩʌĮȡĮıțİȣĮıȝȑȞȠʌȡȩıĳĮĲĮıȪȝĳȦȞĮȝİĲȚȢȠįȘȖȓİȢĲȠȣțĮĲĮıțİȣĮıĲȒ ȈǾȂǼǿȍȈǾǼȐȞįİȞȣʌȐȡȤİȚįȚĮșȑıȚȝȘıȣıțİȣȒțĮșĮȡȚıȝȠȪȝİȣʌİȡȒȤȠȣȢıȣȞİȤȓıĲİĲȘȞİȝȕȐʌĲȚıȘĲȠȞțĮșĮȡȚıȝȩıİ İȞȗȣȝȚțȩĮʌȠȡȡȣʌĮȞĲȚțȩİʌȓȜİʌĲȐĲȠȣȜȐȤȚıĲȠȞ ǼțʌȜȪȞİĲİȝİĮʌİıĲĮȖȝȑȞȠȞİȡȩĲĮİȟĮȡĲȒȝĮĲĮĲȠȣİȡȖĮȜİȓȠȣıȘȡĮȖȖȠʌȠȓȘıȘȢțĮȚĲȘȞțĮıȑĲĮĮʌȠıĲİȓȡȦıȘȢĲȠȣİȡȖĮȜİȓȠȣ ıȘȡĮȖȖȠʌȠȓȘıȘȢȖȚĮȞĮĮʌȠȝĮțȡȪȞİĲİțȐșİȓȤȞȠȢĮʌȠȡȡȣʌĮȞĲȚțȠȪțĮȚȣʌȠȜİȚȝȝȐĲȦȞǹĳȒıĲİȩȜĮĲĮİȟĮȡĲȒȝĮĲĮĲȠȣİȡȖĮȜİȓȠȣ ıȘȡĮȖȖȠʌȠȓȘıȘȢțĮȚĲȘȢțĮıȑĲĮȢĮʌȠıĲİȓȡȦıȘȢȞĮıĲİȖȞȫıȠȣȞıĲȠȞĮȑȡĮ ȆȡȚȞĮʌȩĲȘȞĮʌȠıĲİȓȡȦıȘİȓȞĮȚıȘȝĮȞĲȚțȩȞĮİȜȑȖȟİĲİȩȜĮĲĮİȟĮȡĲȒȝĮĲĮĲȠȣİȡȖĮȜİȓȠȣıȘȡĮȖȖȠʌȠȓȘıȘȢțĮȚĲȘȞțĮıȑĲĮ ĮʌȠıĲİȓȡȦıȘȢȖȚĮȞĮȕİȕĮȚȦșİȓĲİȩĲȚİȓȞĮȚțĮșĮȡȐțĮȚįİȞĳȑȡȠȣȞȗȘȝȚȑȢȈĲȚȢȗȘȝȚȑȢʌȠȣșĮȝʌȠȡȠȪıĮȞȞĮİȝʌȠįȓıȠȣȞĲȘıȦıĲȒ ȜİȚĲȠȣȡȖȓĮĲȠȣİȡȖĮȜİȓȠȣıȘȡĮȖȖȠʌȠȓȘıȘȢʌİȡȚȜĮȝȕȐȞȠȞĲĮȚȠȚĮȝȣȤȑȢȘİȝʌȜȠțȒĲȦȞıʌİȚȡȦȝȐĲȦȞȠȚȤĮȡĮȖȑȢĲĮ³ıțĮıȓȝĮĲĮ´ȠȚ İʌȚĳĮȞİȚĮțȑȢĮȞȦȝĮȜȓİȢȠȚİȖțȠʌȑȢĲĮȕĮșȠȣȜȫȝĮĲĮțĮȚȠȚȡȦȖȝȑȢīȚĮȞĮȜİȚĲȠȣȡȖİȓıȦıĲȐȘțĮıȑĲĮĮʌȠıĲİȓȡȦıȘȢĲȠȣ İȡȖĮȜİȓȠȣıȘȡĮȖȖȠʌȠȓȘıȘȢșĮʌȡȑʌİȚȞĮĮıĳĮȜȓȗİȚȩĲĮȞțȜİȓȞİȚțĮȚȞĮȝȘĳȑȡİȚțĮȞİȞȩȢİȓįȠȣȢįȠȝȚțȒȕȜȐȕȘ ǹȞĮĲȡȑȟĲİıĲȚȢʌȡȠĳȣȜȐȟİȚȢĮȡțĮȚ ǹʌȠıĲİȓȡȦıȘ ȂİĲȐĮʌȩțĮșĮȡȚıȝȩțĮȚȑȜİȖȤȠȩȜĮĲĮĮʌȠıȣȞĮȡȝȠȜȠȖȘȝȑȞĮİȟĮȡĲȒȝĮĲĮĲȠȣİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢȝİĮȡĲȘȡȚȠĳȜİȕȚțȩșȘțȐȡȚ șĮʌȡȑʌİȚȞĮĲȠʌȠșİĲȠȪȞĲĮȚıĲȘȞțĮıȑĲĮĮʌȠıĲİȓȡȦıȘȢĲȠȣİȡȖĮȜİȓȠȣȆȡȚȞĮʌȩĲȘȤȡȒıȘȘțĮıȑĲĮĮʌȠıĲİȓȡȦıȘȢșĮʌȡȑʌİȚȞĮ ıȣıțİȣȐȗİĲĮȚıİțĮĲȐȜȜȘȜȠʌİȡȚĲȪȜȚȖȝĮĮʌȠıĲİȓȡȦıȘȢĲȠȣİȝʌȠȡȓȠȣıȪȝĳȦȞĮȝİĲȚȢȠįȘȖȓİȢĲȠȣțĮĲĮıțİȣĮıĲȒĲȠȣʌİȡȚĲȣȜȓȖȝĮĲȠȢ ȆȡȠİȚįȠʌȠȓȘıȘȂȘȞıĲȠȚȕȐȗİĲİĲȚȢțĮıȑĲİȢĮʌȠıĲİȓȡȦıȘȢĲȠȣİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢțĮĲȐĲȘįȚȐȡțİȚĮĲȘȢʌİȡȚȩįȠȣ ĮʌȠıĲİȓȡȦıȘȢ ǹʌȠıĲİȚȡȫıĲİĲȠİȡȖĮȜİȓȠįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢȤȡȘıȚȝȠʌȠȚȫȞĲĮȢĲȚȢʌĮȡĮȝȑĲȡȠȣȢĲȠȣțȪțȜȠȣʌȠȣʌȡȠĲȚȝȐĲİ ȂİȤȡȒıȘĮʌȠıĲİȚȡȦĲȒĮĲȝȠȪȝİȝİĲĮĲȩʌȚıȘȕĮȡȪĲȘĲĮȢ ĬİȡȝȠțȡĮıȓĮ &ȒȣȥȘȜȩĲİȡȘ ȋȡȩȞȠȢȑțșİıȘȢ ȜİʌĲȐ ȋȡȩȞȠȢıĲİȖȞȫȝĮĲȠȢ ȜİʌĲȐ ĬİȡȝȠțȡĮıȓĮ&ȒȣȥȘȜȩĲİȡȘ ȋȡȩȞȠȢȑțșİıȘȢ ȜİʌĲȐ ȋȡȩȞȠȢıĲİȖȞȫȝĮĲȠȢ ȜİʌĲȐ ȂİȤȡȒıȘĮʌȠıĲİȚȡȦĲȒĮĲȝȠȪȝİʌȡȠțĮĲİȡȖĮıȓĮțİȞȠȪ ȣȥȘȜȩțİȞȩ ĬİȡȝȠțȡĮıȓĮ &ȒȣȥȘȜȩĲİȡȘ ȋȡȩȞȠȢȑțșİıȘȢ ȜİʌĲȐ ȋȡȩȞȠȢıĲİȖȞȫȝĮĲȠȢ ȜİʌĲȐ ȆȡȠĲȠȪĮȞȠȓȟİĲİĲȠʌİȡȚĲȪȜȚȖȝĮĮʌȠıĲİȓȡȦıȘȢİȜȑȖȟĲİİȐȞȣʌȐȡȤȠȣȞıȤȚıȓȝĮĲĮȝȚțȡȑȢȠʌȑȢȒȐȜȜİȢȗȘȝȚȑȢıĲȠʌİȡȚĲȪȜȚȖȝĮʌȠȣșĮ ȝʌȠȡȠȪıĮȞȞĮįȚĮțȣȕİȪıȠȣȞĲȘıĲİȚȡȩĲȘĲĮǾțĮıȑĲĮșĮʌȡȑʌİȚȞĮıȣıțİȣȐȗİĲĮȚıİțĮĲȐȜȜȘȜȠʌİȡȚĲȪȜȚȖȝĮĮʌȠıĲİȓȡȦıȘȢʌȠȣ įȚĮĲȓșİĲĮȚıĲȠİȝʌȩȡȚȠʌȡȠțİȚȝȑȞȠȣȞĮįȚĮĲȘȡİȓĲĮȚȘıĲİȚȡȩĲȘĲĮȝİĲȐĲȘȞİʌİȟİȡȖĮıȓĮ ȋȡȒıȘĲȠȣİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢ ǹĳĮȚȡȑıĲİĲĮıĲİȓȡĮİȟĮȡĲȒȝĮĲĮĲȠȣİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢȝİĮȡĲȘȡȚȠĳȜİȕȚțȩșȘțȐȡȚĮʌȩĲȘȞțĮıȑĲĮĮʌȠıĲİȓȡȦıȘȢ İĳĮȡȝȩȗȠȞĲĮȢțĮĲȐȜȜȘȜȘȐıȘʌĲȘĲİȤȞȚțȒ īȚĮȞĮıȣȞĮȡȝȠȜȠȖȒıİĲİĲĮıĲİȓȡĮİȟĮȡĲȒȝĮĲĮĲȠȣİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢǺȚįȫıĲİțĮȚıĳȓȟĲİȝİĲȠȤȑȡȚĲȠȐțȡȠıİȑȞĮĮʌȩ ĲĮįȪȠȐțȡĮĲȘȢİʌȚȜİȖȝȑȞȘȢȡȐȕįȠȣȈȪȡİĲİĲȠșȘțȐȡȚİʌȐȞȦıĲȘȡȐȕįȠȑĲıȚȫıĲİĲȠİțĲİșİȚȝȑȞȠȐțȡȠĲȘȢȡȐȕįȠȣʌȠȣĳȑȡİȚ ıʌİȓȡȦȝĮȞĮİțĲİȓȞİĲĮȚʌȑȡĮĮʌȩĲȠȐțȡȠĲȠȣșȘțĮȡȚȠȪȈĲİȡİȫıĲİ ȕȚįȫıĲİ ʌȡȠıİțĲȚțȐĲȘȜĮȕȒİʌȐȞȦıĲȠİțĲİșİȚȝȑȞȠȐțȡȠĲȘȢ ȡȐȕįȠȣʌȠȣĳȑȡİȚıʌİȓȡȦȝĮȈĳȓȟĲİȝİĲȠȤȑȡȚĲȘįȚȐĲĮȟȘĳȡȠȞĲȓȗȠȞĲĮȢȫıĲİȠȚĮȣȤȑȞİȢĲȠȣȐțȡȠȣțĮȚĲȘȢȜĮȕȒȢȞĮİĳĮȡȝȩıȠȣȞ ıĲĮșİȡȐıĲĮȐțȡĮĲȠȣșȘțĮȡȚȠȪ ǹțȠȜȠȣșȒıĲİĲȣʌȚțȒȤİȚȡȠȣȡȖȚțȒʌȡĮțĲȚțȒȖȚĮȞĮİțĲİȜȑıİĲİĲȚȢĲȠȝȑȢİȚıȩįȠȣțĮȚİȟȩįȠȣȖȚĮĲȠİȡȖĮȜİȓȠįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢ ȋȡȘıȚȝȠʌȠȚȒıĲİĲȠıĲİȓȡȠıȣȞĮȡȝȠȜȠȖȘȝȑȞȠİȡȖĮȜİȓȠįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢȖȚĮȞĮįȘȝȚȠȣȡȖȒıİĲİȝȚĮıȒȡĮȖȖĮıĲȠȞȚıĲȩȘȠʌȠȓĮȞĮ ıȣȞįȑİȚĲȚȢĲȠȝȑȢİȚıȩįȠȣțĮȚİȟȩįȠȣ ǵĲĮȞĲȠİȡȖĮȜİȓȠįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢįȚȑȜșİȚĮʌȩĲȠıȘȝİȓȠĲȘȢĲȠȝȒȢİȟȩįȠȣįȘȝȚȠȣȡȖȫȞĲĮȢȝȚĮȚțĮȞȠʌȠȚȘĲȚțȒıȒȡĮȖȖĮȟİȕȚįȫıĲİ ĲȘȜĮȕȒțĮĲȐȝȚıȒıĲȡȠĳȒțĮȚıĲȘıȣȞȑȤİȚĮĮĳĮȚȡȑıĲİİȞĲİȜȫȢĲȠȐțȡȠĮʌȩĲȘȡȐȕįȠ (23)

ǹĳȠȪȠȜȠțȜȘȡȦșİȓȘįȚȐȞȠȚȟȘĲȘȢıȒȡĮȖȖĮȢțĮȚĲȠȐțȡȠįİȞȤȡİȚȐȗİĲĮȚʌȜȑȠȞȖȚĮĲȠȣʌȩȜȠȚʌȠĲȘȢįȚĮįȚțĮıȓĮȢĮʌȠȝĮțȡȪȞİĲİĲȠ ȐțȡȠĮʌȩĲȠȤİȚȡȠȣȡȖȚțȩʌİįȓȠțĮȚİʌȚıĲȡȑȥĲİĲȠıĲȘȞțĮıȑĲĮĮʌȠıĲİȓȡȦıȘȢĲȠȣİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢ ȉȠʌȠșȑĲȘıȘĲȠȣĮȡĲȘȡȚȠĳȜİȕȚțȠȪȝȠıȤİȪȝĮĲȠȢ ǼʌȚȜȠȖȒǹĳȠȪȕİȕĮȚȦșİȓĲİȩĲȚĲȠșȘțȐȡȚȕȡȓıțİĲĮȚıĲȘȞțĮȜȪĲİȡȘįȣȞĮĲȒșȑıȘĮʌȠȝĮțȡȪȞİĲİĲȠıȪıĲȘȝĮȡȐȕįȠȣțĮȚȜĮȕȒȢ ĮĳȒȞȠȞĲĮȢ ĲȠșȘțȐȡȚıĲȘșȑıȘĲȠȣǼȚıĮȖȐȖİĲİĲȠȝȩıȤİȣȝĮıĲȠșȘțȐȡȚİĳĮȡȝȩȗȠȞĲĮȢȝȑșȠįȠİȜĮĳȡȐȢȫșȘıȘȢȂȘıȣıĲȡȑĳİĲİĲȠ ȝȩıȤİȣȝĮȆĮȡĮĲȘȡȒıĲİĲȘȖȡĮȝȝȒʌȡȠıĮȞĮĲȠȜȚıȝȠȪȖȚĮȞĮİʌȚȕİȕĮȚȫıİĲİĲȘȞĮțȡȚȕȒĲȠʌȠșȑĲȘıȘǹĳȠȪĲȠȝȩıȤİȣȝĮĲȠʌȠșİĲȘșİȓ ıĲȘșȑıȘĲȠȣȝȑıĮıĲȠșȘțȐȡȚțȡĮĲȒıĲİĲȠȝȩıȤİȣȝĮıĲȠıȘȝİȓȠĲȘȢĲȠȝȒȢİȟȩįȠȣʌȚȐıĲİĲȠȐțȡȠĲȠȣșȘțĮȡȚȠȪʌȠȣʌȡȠİȟȑȤİȚțĮȚ ĲȡĮȕȒȟĲİ ĮĳĮȚȡȑıĲİ ʌȡȠıİțĲȚțȐĲȠșȘțȐȡȚĮʌȩĲȘıȒȡĮȖȖĮĲȠȣȚıĲȠȪĮĳȒȞȠȞĲĮȢĲȠȝȩıȤİȣȝĮĲȠʌȠșİĲȘȝȑȞȠțĮĲȐȜȜȘȜĮȝȑıĮıĲȘ ıȒȡĮȖȖĮĲȠȣȚıĲȠȪ ǹȞĮĲȡȑȟĲİıĲȘȞʌȡȠĳȪȜĮȟȘĮȡ ǼʌȚȜȠȖȒȈĲİȡİȫıĲİ įȑıĲİ ĲȠȝȩıȤİȣȝĮİʌȐȞȦıĲȘȡȐȕįȠĲȠʌȠșİĲȫȞĲĮȢȑȞĮȡȐȝȝĮįȚĮȝȑıȠȣĲȘȢțȦȞȚțȒȢȠʌȒȢıĲȠȐțȡȠĲȘȢ ȡȐȕįȠȣǺİȕĮȚȦșİȓĲİȩĲȚȘİȟȦĲİȡȚțȒįȚȐȝİĲȡȠȢĲȠȣĮȖȖİȚĮțȠȪȝȠıȤİȪȝĮĲȠȢįİȞȣʌİȡȕĮȓȞİȚĲȘȞİıȦĲİȡȚțȒįȚȐȝİĲȡȠĲȠȣșȘțĮȡȚȠȪțĮȚȩĲȚ ĲȠȝȒțȠȢĲȠȣȝȠıȤİȪȝĮĲȠȢİȓȞĮȚȝİȖĮȜȪĲİȡȠĮʌȩĲȘıȒȡĮȖȖĮĲȠȣȚıĲȠȪȉȡĮȕȒȟĲİʌȡȠıİțĲȚțȐĲȠȝȩıȤİȣȝĮįȚĮȝȑıȠȣĲȠȣșȘțĮȡȚȠȪ ȤȡȘıȚȝȠʌȠȚȫȞĲĮȢĲȠıȪıĲȘȝĮȜĮȕȒȢțĮȚȡȐȕįȠȣǹĳȠȪĲȠȝȩıȤİȣȝĮĲȡĮȕȘȤĲİȓıĲȘșȑıȘĲȠȣȝȑıĮıĲȠșȘțȐȡȚĮʌİȜİȣșİȡȫıĲİĲȠĮʌȩ ĲȘȡȐȕįȠțȩȕȠȞĲĮȢĲȠȡȐȝȝĮȀȡĮĲȫȞĲĮȢĲȠȝȩıȤİȣȝĮıĲȠıȘȝİȓȠĲȘȢĲȠȝȒȢİȟȩįȠȣʌȚȐıĲİĲȠȐțȡȠĲȠȣșȘțĮȡȚȠȪʌȠȣʌȡȠİȟȑȤİȚțĮȚ ĲȡĮȕȒȟĲİ ĮĳĮȚȡȑıĲİ ʌȡȠıİțĲȚțȐĲȠșȘțȐȡȚĮʌȩĲȘıȒȡĮȖȖĮĲȠȣȚıĲȠȪĮĳȒȞȠȞĲĮȢĲȠȝȩıȤİȣȝĮĲȠʌȠșİĲȘȝȑȞȠțĮĲȐȜȜȘȜĮȝȑıĮıĲȘ ıȒȡĮȖȖĮĲȠȣȚıĲȠȪȆȡȠȤȦȡȒıĲİıĲȘȞĮȞĮıĲȩȝȦıȘĲȠȣĮȖȖİȓȠȣ ǹȞĮĲȡȑȟĲİıĲȘȞʌȡȠĳȪȜĮȟȘĮȡ ǻȚĮįȚțĮıȓİȢıȣȞĲȒȡȘıȘȢ īȚĮĲȘıȦıĲȒıȣȞĲȒȡȘıȘĲȠȣİȡȖĮȜİȓȠȣįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢȝİĮȡĲȘȡȚȠĳȜİȕȚțȩșȘțȐȡȚĮʌĮȚĲİȓĲĮȚʌȡȠıİțĲȚțȩȢȤİȚȡȚıȝȩȢțĮȚȑȜİȖȤȠȢțȐșİ İȟĮȡĲȒȝĮĲȠȢĲȠȣİȡȖĮȜİȓȠȣțĮșȫȢțĮȚĲȘȢțĮıȑĲĮȢĮʌȠıĲİȓȡȦıȘȢĲȠȣİȡȖĮȜİȓȠȣǹʌĮȚĲİȓĲĮȚȚįȚĮȓĲİȡȘʌȡȠıȠȤȒȖȚĮȞĮĮʌȠĳİȪȖİĲĮȚȘ ʌȡȩțȜȘıȘȗȘȝȚȐȢıĲĮĲȝȒȝĮĲĮĲȘȢȡȐȕįȠȣĲȘȢȜĮȕȒȢțĮȚĲȠȣȐțȡȠȣʌȠȣĳȑȡȠȣȞıʌİȓȡȦȝĮǼȐȞĮȣĲȑȢȠȚʌİȡȚȠȤȑȢȑȤȠȣȞȣʌȠıĲİȓȗȘȝȚȐ ȜȩȖȦİıĳĮȜȝȑȞȠȣȤİȚȡȚıȝȠȪ ʌȤȜȩȖȦʌĲȫıȘȢİȝʌȜȠțȒȢĲȦȞıʌİȚȡȦȝȐĲȦȞȕȠȣȡĲıȓıȝĮĲȠȢțĮȚȒțĮșĮȡȚıȝȠȪȝİįȚĮȕȡȦĲȚțȐȝȑıĮ ĲĮ İȟĮȡĲȒȝĮĲĮʌȚșĮȞȩȞȞĮȝȘȞİĳĮȡȝȩȗȠȣȞıȦıĲȐȝİĲĮȟȪĲȠȣȢȂȘȞȤȡȘıȚȝȠʌȠȚİȓĲİĲȠİȡȖĮȜİȓȠįȚȐȞȠȚȟȘȢıȒȡĮȖȖĮȢİȐȞʌȡȠțȪȥİȚĲȑĲȠȚȠȣ İȓįȠȣȢȗȘȝȚȐǼʌȚțȠȚȞȦȞȒıĲİȝİĲȘȞ%DUG3HULSKHUDO9DVFXODUȖȚĮĲĮțĮĲȐȜȜȘȜĮĮȞĲĮȜȜĮțĲȚțȐțĮȚȖȚĮʌȜȘȡȠĳȠȡȓİȢʌĮȡĮȖȖİȜȚȫȞ ǼȖȖȪȘıȘ Ǿ%DUG3HULSKHUDO9DVFXODU,QFʌĮȡȑȤİȚİȖȖȪȘıȘʌȡȠȢĲȠȞĮȡȤȚțȩĮȖȠȡĮıĲȒĲȠȣʌȡȠȧȩȞĲȠȢĮȣĲȠȪȩĲȚĲȠʌȡȠȧȩȞĮȣĲȩİȓȞĮȚĮʌĮȜȜĮȖȝȑȞȠ ĮʌȩİȜĮĲĲȫȝĮĲĮȩıȠȞĮĳȠȡȐĲĮȣȜȚțȐțĮȚĲȘȞțĮĲĮıțİȣȒȖȚĮʌİȡȓȠįȠİȞȩȢȑĲȠȣȢĮʌȩĲȘȞȘȝİȡȠȝȘȞȓĮĲȘȢʌȡȫĲȘȢĮȖȠȡȐȢǾİȣșȪȞȘıĲĮ ʌȜĮȓıȚĮĮȣĲȒȢĲȘȢʌİȡȚȠȡȚıȝȑȞȘȢİȖȖȪȘıȘȢʌİȡȚȠȡȓȗİĲĮȚıĲȘȞİʌȚıțİȣȒȒĮȞĲȚțĮĲȐıĲĮıȘĲȠȣİȜĮĲĲȦȝĮĲȚțȠȪʌȡȠȧȩȞĲȠȢțĮĲȐĲȘȞ ĮʌȠțȜİȚıĲȚțȒțȡȓıȘĲȘȢ%DUG3HULSKHUDO9DVFXODUȒıĲȘȞİʌȚıĲȡȠĳȒĲȘȢțĮșĮȡȒȢĲȚȝȒȢʌȠȣțĮĲĮȕȜȒșȘțİǾʌĮȡȠȪıĮʌİȡȚȠȡȚıȝȑȞȘ İȖȖȪȘıȘįİȞțĮȜȪʌĲİȚʌİȡȚʌĲȫıİȚȢĳșȠȡȐȢȜȩȖȦĳȣıȚȠȜȠȖȚțȒȢȤȡȒıȘȢȒİȜĮĲĲȫȝĮĲĮʌȠȣȠĳİȓȜȠȞĲĮȚıİİıĳĮȜȝȑȞȘȤȡȒıȘĲȠȣʌȡȠȧȩȞĲȠȢ ĮȣĲȠȪ ȈȉȅȂǼȉȇȅȆȅȊǼȆǿȉȇǼȆǼȉǹǿǹȆȅȉǾȃǿȈȋȊȅȊȈǹȃȅȂȅĬǼȈǿǹǾȆǼȇǿȅȇǿȈȂǼȃǾǹȊȉǾǼīīȊǾȈǾȊȆȅȀǹĬǿȈȉǹȀǹĬǼ ǹȁȁǾǼīīȊǾȈǾǼǿȉǼȇǾȉǾǼǿȉǼǼȂȂǼȈǾȈȊȂȆǼȇǿȁǹȂǺǹȃȅȂǼȃǾȈȂǼȉǹȄȊǹȁȁȍȃȀǹǿȀǹĬǼǼȂȂǼȈǾȈǼīīȊǾȈǾȈ ǼȂȆȅȇǼȊȈǿȂȅȉǾȉǹȈǳȀǹȉǹȁȁǾȁȅȉǾȉǹȈīǿǹȀǹȆȅǿȅȈȊīȀǼȀȇǿȂǼȃȅȈȀȅȆȅ+%$5'3(5,3+(5$/9$6&8/$5ǻǼȃ ǹȃǹȁǹȂǺǹȃǼǿȅȊǻǼȂǿǹǼȊĬȊȃǾīǿǹȉȊȋȅȃǼȂȂǼȈǼȈȉȊȋǹǿǼȈǳȆǹȇǼȆȅȂǼȃǼȈǽǾȂǿǼȈȆȅȊȆȇȅȀȊȆȉȅȊȃǹȆȅȉȅ ȋǼǿȇǿȈȂȅǳȉǾȋȇǾȈǾȉȅȊȆȇȅȎȅȃȉȅȈǹȆȅȂǼȇȅȊȈȈǹȈ ȅȡȚıȝȑȞİȢʌȠȜȚĲİȓİȢȤȫȡİȢįİȞİʌȚĲȡȑʌȠȣȞĲȘȞİȟĮȓȡİıȘĲȦȞȣʌȠȞȠȠȪȝİȞȦȞİȖȖȣȒıİȦȞĲȦȞĲȣȤĮȓȦȞȒĮʌȠșİĲȚțȫȞȗȘȝȚȫȞȂʌȠȡİȓȞĮ įȚțĮȚȠȪıĲİʌȡȩıșİĲĮȝȑĲȡĮĮʌȠțĮĲȐıĲĮıȘȢıȪȝĳȦȞĮȝİĲȠȣȢȞȩȝȠȣȢĲȘȢʌȠȜȚĲİȓĮȢĲȘȢȤȫȡĮȢıĮȢ īȚĮĲȘȞİȞȘȝȑȡȦıȘĲȠȣȤȡȒıĲȘıĲȘȞĲİȜİȣĲĮȓĮıİȜȓįĮĲȠȣʌĮȡȩȞĲȠȢĳȣȜȜĮįȓȠȣʌİȡȚȜĮȝȕȐȞİĲĮȚȝȚĮȘȝİȡȠȝȘȞȓĮȑțįȠıȘȢȒĮȞĮșİȫȡȘıȘȢ țĮȚȑȞĮȢĮȡȚșȝȩȢĮȞĮșİȫȡȘıȘȢȖȚĮĲȚȢıȣȖțİțȡȚȝȑȞİȢȠįȘȖȓİȢȈĲȘȞʌİȡȓʌĲȦıȘʌȠȣȑȤȠȣȞʌİȡȐıİȚȝȒȞİȢĮʌȩĮȣĲȒȞĲȘȞȘȝİȡȠȝȘȞȓĮ țĮȚĲȘȤȡȒıȘĲȠȣʌȡȠȧȩȞĲȠȢȠȤȡȒıĲȘȢʌȡȑʌİȚȞĮİʌȚțȠȚȞȦȞȒıİȚȝİĲȘȞ%DUG3HULSKHUDO9DVFXODU,QFȖȚĮȞĮįİȚĮȞİȓȞĮȚįȚĮșȑıȚȝİȢ ʌȡȩıșİĲİȢʌȜȘȡȠĳȠȡȓİȢȖȚĮĲȠʌȡȠȧȩȞ

(24)

ɞɥɹɫɬɟɪɢɥɢɡɚɰɢɢɬɭɧɧɟɥɢɡɚɬɨɪɚɦɨɠɟɬɢɫɩɨɥɶɡɨɜɚɬɶɫɹɫɢɫɬɟɦɚɦɟɯɚɧɢɱɟɫɤɨɣɨɱɢɫɬɤɢɢɥɢɪɭɱɧɨɣɫɩɨɫɨɛɨɱɢɫɬɤɢ Ɉɛɪɚɬɢɬɟɫɶɤɢɧɫɬɪɭɤɰɢɹɦɩɨɨɱɢɫɬɤɟɯɢɪɭɪɝɢɱɟɫɤɢɯɢɧɫɬɪɭɦɟɧɬɨɜɨɬɩɪɨɢɡɜɨɞɢɬɟɥɟɣɫɢɫɬɟɦɵɦɟɯɚɧɢɱɟɫɤɨɣɨɱɢɫɬɤɢ ɢɱɢɫɬɹɳɢɯɫɪɟɞɫɬɜ ɉɪɟɞɥɚɝɚɟɬɫɹɢɫɩɨɥɶɡɨɜɚɬɶɫɥɟɞɭɸɳɭɸɦɟɬɨɞɢɤɭɪɭɱɧɨɣɨɱɢɫɬɤɢ ɂɫɩɨɥɶɡɭɣɬɟɩɨɞɯɨɞɹɳɢɟɳɟɬɤɢɫɨɜɦɟɫɬɢɦɵɟɫɯɢɪɭɪɝɢɱɟɫɤɢɦɢɢɧɫɬɪɭɦɟɧɬɚɦɢɜɵɩɨɥɧɟɧɧɵɦɢɢɡɧɟɪɠɚɜɟɸɳɟɣɫɬɚɥɢ ɞɥɹɨɱɢɫɬɤɢɜɧɭɬɪɟɧɧɟɝɨɩɪɨɫɜɟɬɚɨɛɨɥɨɱɤɢɢɳɟɥɟɣɧɚɪɟɡɶɛɨɜɵɯɱɚɫɬɹɯɫɬɟɪɠɧɹɧɚɤɨɧɟɱɧɢɤɚɢɪɭɤɨɹɬɤɢɍɞɚɥɢɬɟɜɫɟ ɧɚɥɢɩɲɢɟɱɚɫɬɢɰɵɬɤɚɧɢɢɜɵɫɨɯɲɭɸɤɪɨɜɶɫɤɚɫɫɟɬɵɞɥɹɫɬɟɪɢɥɢɡɚɰɢɢɬɭɧɧɟɥɢɡɚɬɨɪɚɢɨɬɞɟɥɶɧɵɯɤɨɦɩɨɧɟɧɬɨɜ ɬɭɧɧɟɥɢɡɚɬɨɪɚɫɩɨɦɨɳɶɸɩɪɨɯɥɚɞɧɨɣɩɪɨɬɨɱɧɨɣɜɨɞɨɩɪɨɜɨɞɧɨɣɜɨɞɵɢɫɩɨɥɶɡɭɹɩɨɞɯɨɞɹɳɢɟɳɟɬɤɢɞɥɹɨɱɢɫɬɤɢ ɜɧɭɬɪɟɧɧɟɝɨɩɪɨɫɜɟɬɚɨɛɨɥɨɱɤɢɢɳɟɥɟɣɧɚɪɟɡɶɛɨɜɵɯɱɚɫɬɹɯɫɬɟɪɠɧɹɧɚɤɨɧɟɱɧɢɤɚɢɪɭɤɨɹɬɤɢɁɚɬɟɦɤɨɦɩɨɧɟɧɬɵ ɬɭɧɧɟɥɢɡɚɬɨɪɚɢɤɚɫɫɟɬɭɫɥɟɞɭɟɬɡɚɦɨɱɢɬɶɜɜɨɞɟɫɞɨɛɚɜɥɟɧɢɟɦɦɹɝɤɨɝɨɮɟɪɦɟɧɬɚɬɢɜɧɨɝɨɦɨɸɳɟɝɨɫɪɟɞɫɬɜɚ ɉɨɞɝɨɬɨɜɶɬɟɪɚɫɬɜɨɪɮɟɪɦɟɧɬɚɬɢɜɧɨɝɨɦɨɸɳɟɝɨɫɪɟɞɫɬɜɚɜɫɨɨɬɜɟɬɫɬɜɢɢɫɢɧɫɬɪɭɤɰɢɹɦɢɢɡɝɨɬɨɜɢɬɟɥɹɦɨɸɳɟɝɨɫɪɟɞɫɬɜɚ Ɂɚɦɨɱɢɬɟɤɨɦɩɨɧɟɧɬɵɬɭɧɧɟɥɢɡɚɬɨɪɚɢɤɚɫɫɟɬɭɧɚɞɟɫɹɬɶɦɢɧɭɬɉɪɨɦɨɣɬɟɤɨɦɩɨɧɟɧɬɵɬɭɧɧɟɥɢɡɚɬɨɪɚɢɤɚɫɫɟɬɭɞɥɹ ɫɬɟɪɢɥɢɡɚɰɢɢɬɭɧɧɟɥɢɡɚɬɨɪɚɜɞɢɫɬɢɥɥɢɪɨɜɚɧɧɨɣɜɨɞɟɱɬɨɛɵɭɞɚɥɢɬɶɜɫɟɫɥɟɞɵɦɨɸɳɢɯɫɪɟɞɫɬɜɢɡɚɝɪɹɡɧɟɧɢɣ ɉɨɦɟɫɬɢɬɟɤɨɦɩɨɧɟɧɬɵɪɚɡɨɛɪɚɧɧɨɝɨɬɭɧɧɟɥɢɡɚɬɨɪɚɜɭɫɬɪɨɣɫɬɜɨɞɥɹɭɥɶɬɪɚɡɜɭɤɨɜɨɣɨɱɢɫɬɤɢɫɨɫɜɟɠɟɩɪɢɝɨɬɨɜɥɟɧɧɵɦ ɜɫɨɨɬɜɟɬɫɬɜɢɢɫɢɧɫɬɪɭɤɰɢɹɦɢɢɡɝɨɬɨɜɢɬɟɥɹ ɮɟɪɦɟɧɬɚɬɢɜɧɵɦɦɨɸɳɢɦɫɪɟɞɫɬɜɨɦɦɢɧɢɦɭɦɧɚɦɢɧɭɬ ɉɊɂɆȿɑȺɇɂȿɉɪɢɨɬɫɭɬɫɬɜɢɢɜɨɡɦɨɠɧɨɫɬɢɢɫɩɨɥɶɡɨɜɚɬɶɭɫɬɪɨɣɫɬɜɨɞɥɹɭɥɶɬɪɚɡɜɭɤɨɜɨɣɨɱɢɫɬɤɢɩɪɨɞɨɥɠɚɣɬɟɡɚɦɚɱɢɜɚɧɢɟ ɨɱɢɫɬɤɭɜɮɟɪɦɟɧɬɚɬɢɜɧɨɦɦɨɸɳɟɦɫɪɟɞɫɬɜɟɜɬɟɱɟɧɢɟɦɢɧɢɦɭɦɦɢɧɭɬ ɉɪɨɦɨɣɬɟɤɨɦɩɨɧɟɧɬɵɬɭɧɧɟɥɢɡɚɬɨɪɚɢɤɚɫɫɟɬɭɞɥɹɫɬɟɪɢɥɢɡɚɰɢɢɬɭɧɧɟɥɢɡɚɬɨɪɚɜɞɢɫɬɢɥɥɢɪɨɜɚɧɧɨɣɜɨɞɟɱɬɨɛɵ ɭɞɚɥɢɬɶɜɫɟɫɥɟɞɵɦɨɸɳɢɯɫɪɟɞɫɬɜɢɡɚɝɪɹɡɧɟɧɢɣȾɚɣɬɟɜɫɟɦɤɨɦɩɨɧɟɧɬɚɦɬɭɧɧɟɥɢɡɚɬɨɪɚɢɤɚɫɫɟɬɟɞɥɹɫɬɟɪɢɥɢɡɚɰɢɢ ɬɭɧɧɟɥɢɡɚɬɨɪɚɜɵɫɨɯɧɭɬɶɧɚɜɨɡɞɭɯɟ ɉɟɪɟɞɫɬɟɪɢɥɢɡɚɰɢɟɣɜɚɠɧɨɩɪɨɜɟɪɢɬɶɜɫɟɤɨɦɩɨɧɟɧɬɵɬɭɧɧɟɥɢɡɚɬɨɪɚɢɤɚɫɫɟɬɭɞɥɹɫɬɟɪɢɥɢɡɚɰɢɢɬɭɧɧɟɥɢɡɚɬɨɪɚɱɬɨɛɵ ɭɛɟɞɢɬɶɫɹɜɢɯɱɢɫɬɨɬɟɢɨɬɫɭɬɫɬɜɢɢɩɨɜɪɟɠɞɟɧɢɣɉɨɜɪɟɠɞɟɧɢɹɤɨɬɨɪɵɟɦɨɝɭɬɜɨɫɩɪɟɩɹɬɫɬɜɨɜɚɬɶɧɚɞɥɟɠɚɳɟɣ ɪɟɚɥɢɡɚɰɢɢɮɭɧɤɰɢɢɬɭɧɧɟɥɢɡɚɬɨɪɚɜɤɥɸɱɚɸɬɰɚɪɚɩɢɧɵɫɜɢɧɱɢɜɚɧɢɟɪɟɡɶɛɵɪɚɡɴɟɞɚɧɢɟɦɚɬɟɪɢɚɥɚɬɨɱɟɱɧɭɸ ɤɨɪɪɨɡɢɸɩɨɹɜɥɟɧɢɟɡɚɭɫɟɧɰɟɜɡɚɡɭɛɪɢɧɜɦɹɬɢɧɢɥɢɬɪɟɳɢɧȾɥɹɧɚɞɥɟɠɚɳɟɝɨɢɫɩɨɥɶɡɨɜɚɧɢɹɤɚɫɫɟɬɚɞɥɹ ɫɬɟɪɢɥɢɡɚɰɢɢɬɭɧɧɟɥɢɡɚɬɨɪɚɜɡɚɤɪɵɬɨɦɜɢɞɟɞɨɥɠɧɚɛɵɬɶɡɚɩɟɪɬɚɧɚɡɚɳɟɥɤɭɢɧɟɞɨɥɠɧɚɢɦɟɬɶɧɢɤɚɤɢɯɫɬɪɭɤɬɭɪɧɵɯ ɩɨɜɪɟɠɞɟɧɢɣ ɋɦɦɟɪɵɩɪɟɞɨɫɬɨɪɨɠɧɨɫɬɢʋʋɢʋ ɋɬɟɪɢɥɢɡɚɰɢɹ ɉɨɫɥɟɨɱɢɫɬɤɢɢɩɪɨɜɟɪɤɢɜɫɟɤɨɦɩɨɧɟɧɬɵɪɚɡɨɛɪɚɧɧɨɝɨȺȼɬɭɧɧɟɥɢɡɚɬɨɪɚɫɨɛɨɥɨɱɤɨɣɞɨɥɠɧɵɛɵɬɶɩɨɦɟɳɟɧɵɜɤɚɫɫɟɬɭɞɥɹ ɫɬɟɪɢɥɢɡɚɰɢɢɬɭɧɧɟɥɢɡɚɬɨɪɚɉɟɪɟɞɢɫɩɨɥɶɡɨɜɚɧɢɟɦɤɚɫɫɟɬɚɞɥɹɫɬɟɪɢɥɢɡɚɰɢɢɬɭɧɧɟɥɢɡɚɬɨɪɚɞɨɥɠɧɚɛɵɬɶɡɚɤɥɸɱɟɧɚ ɜɫɨɨɬɜɟɬɫɬɜɭɸɳɭɸɤɨɦɦɟɪɰɢɚɥɢɡɢɪɨɜɚɧɧɭɸɫɬɟɪɢɥɢɡɚɰɢɨɧɧɭɸɭɩɚɤɨɜɤɭɢɫɩɨɥɶɡɭɟɦɭɸɜɫɨɨɬɜɟɬɫɬɜɢɢɫɢɧɫɬɪɭɤɰɢɹɦɢ ɢɡɝɨɬɨɜɢɬɟɥɹɭɩɚɤɨɜɤɢ ɉɪɟɞɭɩɪɟɠɞɟɧɢɟȼɨɜɪɟɦɹɩɟɪɢɨɞɚɫɬɟɪɢɥɢɡɚɰɢɢɧɟɫɤɥɚɞɵɜɚɬɶɤɚɫɫɟɬɵɞɥɹɫɬɟɪɢɥɢɡɚɰɢɢɬɭɧɧɟɥɢɡɚɬɨɪɨɜɜɫɬɨɩɤɭ ɋɬɟɪɢɥɢɡɭɣɬɟɬɭɧɧɟɥɢɡɚɬɨɪɩɪɢɞɟɪɠɢɜɚɹɫɶɫɬɚɧɞɚɪɬɧɵɯɩɚɪɚɦɟɬɪɨɜɰɢɤɥɚ ɂɫɩɨɥɶɡɨɜɚɧɢɟɩɚɪɨɜɨɝɨɫɬɟɪɢɥɢɡɚɬɨɪɚɫɝɪɚɜɢɬɚɰɢɨɧɧɵɦɜɵɬɟɫɧɟɧɢɟɦ Ɍɟɦɩɟɪɚɬɭɪɚ & ) ɢɥɢɜɵɲɟ ȼɪɟɦɹɨɛɪɚɛɨɬɤɢ ɦɢɧɭɬ ȼɪɟɦɹɫɭɲɤɢ ɦɢɧɭɬ Ɍɟɦɩɟɪɚɬɭɪɚ& ) ɢɥɢɜɵɲɟ ȼɪɟɦɹɨɛɪɚɛɨɬɤɢ ɦɢɧɭɬ ȼɪɟɦɹɫɭɲɤɢ ɦɢɧɭɬ ɂɫɩɨɥɶɡɨɜɚɧɢɟɩɪɟɜɚɤɭɭɦɧɨɝɨɩɚɪɨɜɨɝɨɫɬɟɪɢɥɢɡɚɬɨɪɚ ɪɟɠɢɦɝɥɭɛɨɤɨɝɨɜɚɤɭɭɦɚ Ɍɟɦɩɟɪɚɬɭɪɚ & ) ɢɥɢɜɵɲɟ ȼɪɟɦɹɨɛɪɚɛɨɬɤɢ ɦɢɧɭɬɵ ȼɪɟɦɹɫɭɲɤɢ ɦɢɧɭɬ ɉɟɪɟɞɬɟɦɤɚɤɨɬɤɪɵɬɶɫɬɟɪɢɥɢɡɚɰɢɨɧɧɭɸɭɩɚɤɨɜɤɭɨɫɦɨɬɪɢɬɟɟɟɧɚɩɪɟɞɦɟɬɧɚɥɢɱɢɹɪɚɡɪɵɜɨɜɩɪɨɤɨɥɨɜɢɥɢɞɪɭɝɢɯ ɩɨɜɪɟɠɞɟɧɢɣɤɨɬɨɪɵɟɦɨɝɭɬɩɨɫɬɚɜɢɬɶɩɨɞɭɝɪɨɡɭɫɬɟɪɢɥɶɧɨɫɬɶɄɚɫɫɟɬɚɞɨɥɠɧɚɛɵɬɶɡɚɤɥɸɱɟɧɚɜɫɨɨɬɜɟɬɫɬɜɭɸɳɭɸ ɤɨɦɦɟɪɱɟɫɤɢɞɨɫɬɭɩɧɭɸɫɬɟɪɢɥɢɡɚɰɢɨɧɧɭɸɭɩɚɤɨɜɤɭɫɰɟɥɶɸɫɨɯɪɚɧɟɧɢɹɫɬɟɪɢɥɶɧɨɫɬɢɩɨɫɥɟɨɛɪɚɛɨɬɤɢ ɂɫɩɨɥɶɡɨɜɚɧɢɟɬɭɧɧɟɥɢɡɚɬɨɪɚ ɂɡɜɥɟɤɢɬɟɫɬɟɪɢɥɶɧɵɟɤɨɦɩɨɧɟɧɬɵȺȼɬɭɧɧɟɥɢɡɚɬɨɪɚɫɨɛɨɥɨɱɤɨɣɢɡɤɚɫɫɟɬɵɞɥɹɫɬɟɪɢɥɢɡɚɰɢɢɬɭɧɧɟɥɢɡɚɬɨɪɚɩɪɢ ɩɨɦɨɳɢɫɨɨɬɜɟɬɫɬɜɭɸɳɢɯɚɫɟɩɬɢɱɟɫɤɢɯɦɟɬɨɞɢɤ (50)

ɑɬɨɛɵɫɨɛɪɚɬɶɜɨɟɞɢɧɨɫɬɟɪɢɥɶɧɵɟɤɨɦɩɨɧɟɧɬɵɬɭɧɧɟɥɢɡɚɬɨɪɚɧɚɜɢɧɬɢɬɟɧɚɤɨɧɟɱɧɢɤɧɚɥɸɛɨɣɤɨɧɟɰɜɵɛɪɚɧɧɨɝɨ ɫɬɟɪɠɧɹɢɜɪɭɱɧɭɸɡɚɬɹɧɢɬɟɉɪɨɞɜɢɧɶɬɟɨɛɨɥɨɱɤɭɩɨɫɬɟɪɠɧɸɬɚɤɢɦɨɛɪɚɡɨɦɱɬɨɛɵɫɜɨɛɨɞɧɵɣɤɨɧɟɰɫɬɟɪɠɧɹɫɪɟɡɶɛɨɣ ɜɵɫɬɭɩɚɥɡɚɤɪɚɣɨɛɨɥɨɱɤɢɈɫɬɨɪɨɠɧɨɩɪɢɤɪɟɩɢɬɟ ɧɚɜɢɧɬɢɬɟ ɪɭɤɨɹɬɤɭɤɩɨɥɧɨɫɬɶɸɨɬɤɪɵɬɨɦɭɤɨɧɰɭɫɬɟɪɠɧɹɫɪɟɡɶɛɨɣ ɉɪɨɱɧɨɡɚɬɹɧɢɬɟɫɨɟɞɢɧɟɧɢɹɱɬɨɛɵɨɛɟɫɩɟɱɢɬɶɩɥɨɬɧɨɟɩɪɢɥɟɝɚɧɢɟɜɵɫɬɭɩɨɜɧɚɤɨɧɟɱɧɢɤɚɢɪɭɤɨɹɬɤɢɤɤɪɚɹɦɨɛɨɥɨɱɤɢ ɋɥɟɞɭɣɬɟɫɬɚɧɞɚɪɬɧɨɣɯɢɪɭɪɝɢɱɟɫɤɨɣɩɪɚɤɬɢɤɟɞɥɹɫɨɡɞɚɧɢɹɜɯɨɞɧɨɝɨɢɜɵɯɨɞɧɨɝɨɪɚɡɪɟɡɨɜɞɥɹɩɪɨɞɜɢɠɟɧɢɹ ɬɭɧɧɟɥɢɡɚɬɨɪɚ ɂɫɩɨɥɶɡɭɣɬɟɫɬɟɪɢɥɶɧɵɣɬɭɧɧɟɥɢɡɚɬɨɪɜɫɨɛɪɚɧɧɨɦɫɨɫɬɨɹɧɢɢɞɥɹɫɨɡɞɚɧɢɹɬɤɚɧɟɜɨɝɨɬɭɧɧɟɥɹɫɨɟɞɢɧɹɸɳɟɝɨɜɯɨɞɧɨɣ ɢɜɵɯɨɞɧɨɣɪɚɡɪɟɡɵ ɉɨɫɥɟɬɨɝɨɤɚɤɬɭɧɧɟɥɢɡɚɬɨɪɩɪɨɣɞɟɬɱɟɪɟɡɜɵɯɨɞɧɨɣɪɚɡɪɟɡɢɛɭɞɟɬɫɮɨɪɦɢɪɨɜɚɧɬɭɧɧɟɥɶɭɞɨɜɥɟɬɜɨɪɢɬɟɥɶɧɨɝɨ ɤɚɱɟɫɬɜɚɨɬɜɟɪɧɢɬɟɪɭɤɨɹɬɤɭɧɚɨɛɨɪɨɬɚɚɡɚɬɟɦɩɨɥɧɨɫɬɶɸɫɧɢɦɢɬɟɧɚɤɨɧɟɱɧɢɤɫɨɫɬɟɪɠɧɹ ɉɨɫɥɟɬɨɝɨɤɚɤɬɭɧɧɟɥɢɪɨɜɚɧɢɟɛɭɞɟɬɡɚɜɟɪɲɟɧɨɢɧɚɤɨɧɟɱɧɢɤɭɠɟɧɟɛɭɞɟɬɧɭɠɟɧɞɥɹɜɵɩɨɥɧɟɧɢɹɨɫɬɚɜɲɟɣɫɹɱɚɫɬɢ ɩɪɨɰɟɞɭɪɵɭɛɟɪɢɬɟɧɚɤɨɧɟɱɧɢɤɢɡɨɩɟɪɚɰɢɨɧɧɨɝɨɩɨɥɹɢɜɟɪɧɢɬɟɟɝɨɜɤɚɫɫɟɬɭɞɥɹɫɟɪɢɥɢɡɚɰɢɢɬɭɧɧɟɥɢɡɚɬɨɪɚ ɍɫɬɚɧɨɜɤɚȺȼɲɭɧɬɚ ȼɚɪɢɚɧɬɍɛɟɞɢɜɲɢɫɶɜɨɩɬɢɦɚɥɶɧɨɦɩɨɥɨɠɟɧɢɢɨɛɨɥɨɱɤɢɭɞɚɥɢɬɟɫɨɜɦɟɫɬɧɨɫɬɟɪɠɟɧɶɢɪɭɤɨɹɬɤɭɨɫɬɚɜɢɜɨɛɨɥɨɱɤɭɧɚ ɦɟɫɬɟȼɜɟɞɢɬɟɲɭɧɬɜɨɛɨɥɨɱɤɭɩɪɢɩɨɦɨɳɢɦɟɬɨɞɚɥɟɝɤɢɯɬɨɥɱɤɨɜɇɟɩɟɪɟɤɪɭɱɢɜɚɣɬɟɲɭɧɬȼɢɡɭɚɥɢɡɢɪɭɣɬɟɜɫɩɨɦɨɝɚɬɟɥɶɧɭɸ ɥɢɧɢɸɱɬɨɛɵɩɪɨɜɟɪɢɬɶɩɪɚɜɢɥɶɧɨɫɬɶɪɚɡɦɟɳɟɧɢɹɉɨɫɥɟɪɚɡɦɟɳɟɧɢɹɲɭɧɬɚɜɧɭɬɪɢɨɛɨɥɨɱɤɢɭɞɟɪɠɢɜɚɣɬɟɲɭɧɬɧɚɦɟɫɬɟ ɜɵɯɨɞɧɨɝɨɪɚɡɪɟɡɚɜɨɡɶɦɢɬɟɫɶɡɚɜɵɫɬɭɩɚɸɳɢɣɤɨɧɟɰɨɛɨɥɨɱɤɢɢɨɫɬɨɪɨɠɧɨɩɨɬɹɧɢɬɟ ɭɞɚɥɢɬɟ ɨɛɨɥɨɱɤɭɢɡɬɤɚɧɟɜɨɝɨɬɭɧɧɟɥɹ ɨɫɬɚɜɥɹɹɫɨɨɬɜɟɬɫɬɜɭɸɳɢɦɨɛɪɚɡɨɦɪɚɡɦɟɳɟɧɧɵɣɜɧɭɬɪɢɬɤɚɧɟɜɨɝɨɬɭɧɧɟɥɹɲɭɧɬ ɋɦɦɟɪɵɩɪɟɞɨɫɬɨɪɨɠɧɨɫɬɢʋ ȼɚɪɢɚɧɬɉɪɢɤɪɟɩɢɬɟ ɩɪɢɜɹɠɢɬɟ ɲɭɧɬɤɫɬɟɪɠɧɸɪɚɫɩɨɥɚɝɚɹɲɨɜɩɨɥɢɧɢɢɤɨɧɢɱɟɫɤɨɝɨɨɬɜɟɪɫɬɢɹɧɚɜɵɫɬɭɩɚɸɳɟɦɤɨɧɰɟ ɫɬɟɪɠɧɹɍɛɟɞɢɬɟɫɶɱɬɨɜɧɟɲɧɢɣɞɢɚɦɟɬɪɫɨɫɭɞɢɫɬɨɝɨɲɭɧɬɚɫɨɨɬɜɟɬɫɬɜɭɟɬɨɛɨɥɨɱɤɟɢɱɬɨɞɥɢɧɚɲɭɧɬɚɛɨɥɶɲɟɞɥɢɧɵ ɬɤɚɧɟɜɨɝɨɬɭɧɧɟɥɹɈɫɬɨɪɨɠɧɨɩɪɨɬɹɧɢɬɟɲɭɧɬɱɟɪɟɡɨɛɨɥɨɱɤɭɢɫɩɨɥɶɡɭɹɫɨɜɦɟɫɬɧɨɪɭɤɨɹɬɤɭɢɫɬɟɪɠɟɧɶɉɨɫɥɟɬɨɝɨɤɚɤɲɭɧɬ ɨɤɚɠɟɬɫɹɜɬɹɧɭɬɵɦɜɧɭɬɪɶɨɛɨɥɨɱɤɢɨɫɜɨɛɨɞɢɬɟɟɝɨɨɬɫɬɟɪɠɧɹɪɚɡɪɟɡɚɜɲɨɜɍɞɟɪɠɢɜɚɹɲɭɧɬɧɚɦɟɫɬɟɜɵɯɨɞɧɨɝɨɪɚɡɪɟɡɚ ɜɨɡɶɦɢɬɟɫɶɡɚɜɵɫɬɭɩɚɸɳɢɣɤɨɧɟɰɨɛɨɥɨɱɤɢɢɨɫɬɨɪɨɠɧɨɩɨɬɹɧɢɬɟ ɭɞɚɥɢɬɟ ɨɛɨɥɨɱɤɭɢɡɬɤɚɧɟɜɨɝɨɬɭɧɧɟɥɹɨɫɬɚɜɥɹɹ ɫɨɨɬɜɟɬɫɬɜɭɸɳɢɦɨɛɪɚɡɨɦɪɚɡɦɟɳɟɧɧɵɣɜɧɭɬɪɢɬɤɚɧɟɜɨɝɨɬɭɧɧɟɥɹɲɭɧɬɉɪɢɫɬɭɩɢɬɟɤɫɨɡɞɚɧɢɸɫɨɫɭɞɢɫɬɵɯɚɧɚɫɬɨɦɨɡɨɜ ɋɦɦɟɪɵɩɪɟɞɨɫɬɨɪɨɠɧɨɫɬɢʋ ɉɪɚɜɢɥɚɬɟɯɧɢɱɟɫɤɨɝɨɨɛɫɥɭɠɢɜɚɧɢɹ ɇɚɞɥɟɠɚɳɟɟɬɟɯɧɢɱɟɫɤɨɟɨɛɫɥɭɠɢɜɚɧɢɟȺȼɬɭɧɧɟɥɢɡɚɬɨɪɚɫɨɛɨɥɨɱɤɨɣɬɪɟɛɭɟɬɨɫɬɨɪɨɠɧɨɝɨɨɛɪɚɳɟɧɢɹɢɩɪɨɜɟɪɤɢɤɚɠɞɨɝɨ ɤɨɦɩɨɧɟɧɬɚɬɭɧɧɟɥɢɡɚɬɨɪɚɢɤɚɫɫɟɬɵɞɥɹɫɬɟɪɢɥɢɡɚɰɢɢɬɭɧɧɟɥɢɡɚɬɨɪɚɌɪɟɛɭɟɬɫɹɨɫɨɛɨɟɜɧɢɦɚɧɢɟɱɬɨɛɵɢɡɛɟɠɚɬɶ ɩɨɜɪɟɠɞɟɧɢɣɪɟɡɶɛɨɜɵɯɱɚɫɬɟɣɫɬɟɪɠɧɹɪɭɤɨɹɬɤɢɢɧɚɤɨɧɟɱɧɢɤɚȿɫɥɢɷɬɢɭɱɚɫɬɤɢɩɨɜɪɟɠɞɟɧɵɜɫɥɟɞɫɬɜɢɟɧɟɩɪɚɜɢɥɶɧɨɝɨ ɨɛɪɚɳɟɧɢɹ ɬɟɜɫɥɟɞɫɬɜɢɟɩɚɞɟɧɢɹɫɜɢɧɱɢɜɚɧɢɹɪɟɡɶɛɵɱɢɫɬɤɢɢɢɥɢɨɱɢɫɬɤɢɫɩɨɦɨɳɶɸɚɛɪɚɡɢɜɧɵɯɜɟɳɟɫɬɜ ɱɚɫɬɢɦɨɝɭɬ ɧɟɫɨɱɟɬɚɬɶɫɹɞɪɭɝɫɞɪɭɝɨɦɞɨɥɠɧɵɦɨɛɪɚɡɨɦɉɪɢɩɨɹɜɥɟɧɢɢɩɨɞɨɛɧɵɯɩɨɜɪɟɠɞɟɧɢɣɢɫɩɨɥɶɡɨɜɚɧɢɟɬɭɧɧɟɥɢɡɚɬɨɪɚ ɡɚɩɪɟɳɟɧɨɋɜɹɠɢɬɟɫɶɫɤɨɦɩɚɧɢɟɣ%DUG3HULSKHUDO9DVFXODUɩɨɩɨɜɨɞɭɫɨɨɬɜɟɬɫɬɜɭɸɳɢɯɡɚɩɚɫɧɵɯɱɚɫɬɟɣɢɞɥɹɩɨɥɭɱɟɧɢɹ ɢɧɮɨɪɦɚɰɢɢɞɥɹɡɚɤɚɡɚ Ƚɚɪɚɧɬɢɹ Ʉɨɦɩɚɧɢɹ%DUG3HULSKHUDO9DVFXODU,QFɜɬɟɱɟɧɢɟɨɞɧɨɝɨɝɨɞɚɫɨɞɧɹɩɟɪɜɨɧɚɱɚɥɶɧɨɣɩɨɤɭɩɤɢɝɚɪɚɧɬɢɪɭɟɬɩɟɪɜɨɧɚɱɚɥɶɧɨɦɭ ɩɨɤɭɩɚɬɟɥɸɞɚɧɧɨɝɨɢɡɞɟɥɢɹɨɬɫɭɬɫɬɜɢɟɜɞɚɧɧɨɦɢɡɞɟɥɢɢɞɟɮɟɤɬɨɜɦɚɬɟɪɢɚɥɨɜɢɩɪɨɢɡɜɨɞɫɬɜɟɧɧɨɝɨɛɪɚɤɚɈɬɜɟɬɫɬɜɟɧɧɨɫɬɶ ɩɨɞɚɧɧɨɣɨɝɪɚɧɢɱɟɧɧɨɣɝɚɪɚɧɬɢɢɧɚɢɡɞɟɥɢɟɨɝɪɚɧɢɱɢɜɚɟɬɫɹɪɟɦɨɧɬɨɦɢɥɢɡɚɦɟɧɨɣɧɟɢɫɩɪɚɜɧɨɝɨɢɡɞɟɥɢɹɢɥɢɜɨɡɦɟɳɟɧɢɟɦ ɟɝɨɩɨɥɧɨɣɫɬɨɢɦɨɫɬɢɩɨɭɫɦɨɬɪɟɧɢɸɤɨɦɩɚɧɢɢ%DUG3HULSKHUDO9DVFXODUȾɚɧɧɚɹɨɝɪɚɧɢɱɟɧɧɚɹɝɚɪɚɧɬɢɹɧɟɩɨɤɪɵɜɚɟɬ ɧɨɪɦɚɥɶɧɵɣɢɡɧɨɫɚɬɚɤɠɟɧɟɢɫɩɪɚɜɧɨɫɬɢɩɪɨɢɫɬɟɤɚɸɳɢɟɢɡɢɫɩɨɥɶɡɨɜɚɧɢɹɢɡɞɟɥɢɹɧɟɩɨɧɚɡɧɚɱɟɧɢɸ ȼɈȻɔȿɆȿɉɊȿȾɍɋɆɈɌɊȿɇɇɈɆȾȿɃɋɌȼɍɘɓɂɆɁȺɄɈɇɈȾȺɌȿɅɖɋɌȼɈɆȾȺɇɇȺəɈȽɊȺɇɂɑȿɇɇȺəȽȺɊȺɇɌɂəɇȺ ɂɁȾȿɅɂȿɂɋɄɅɘɑȺȿɌȼɋȿɈɋɌȺɅɖɇɕȿȽȺɊȺɇɌɂɂəȼɇɕȿɂɅɂɉɈȾɊȺɁɍɆȿȼȺȿɆɕȿȼɑȺɋɌɇɈɋɌɂɅɘȻɕȿ ɉɈȾɊȺɁɍɆȿȼȺȿɆɕȿȽȺɊȺɇɌɂɂɄɈɆɆȿɊɑȿɋɄɈɃɉɊɂȽɈȾɇɈɋɌɂɂɅɂɋɈɈɌȼȿɌɋɌȼɂəɈɉɊȿȾȿɅȿɇɇɈɃɐȿɅɂɇɂ ɉɊɂɄȺɄɂɏɍɋɅɈȼɂəɏɄɈɆɉȺɇɂə%$5'3(5,3+(5$/9$6&8/$5ɇȿɇȿɋȿɌɈɌȼȿɌɋɌȼȿɇɇɈɋɌɖɁȺɅɘȻɕȿ ɉɊəɆɕȿɋɅɍɑȺɃɇɕȿɂɅɂɄɈɋȼȿɇɇɕȿɍȻɕɌɄɂɉɊɈɂɋɌȿɄȺɘɓɂȿɂɁɈȻɊȺɓȿɇɂəɋȾȺɇɇɕɆɂɁȾȿɅɂȿɆ ɂɅɂȿȽɈɂɋɉɈɅɖɁɈȼȺɇɂə ȼɧɟɤɨɬɨɪɵɯɪɟɝɢɨɧɚɯɫɬɪɚɧɚɯɧɟɞɟɣɫɬɜɭɟɬɢɫɤɥɸɱɟɧɢɟɩɨɞɪɚɡɭɦɟɜɚɟɦɵɯɝɚɪɚɧɬɢɣɫɥɭɱɚɣɧɵɯɢɥɢɤɨɫɜɟɧɧɵɯɭɛɵɬɤɨɜ ɋɨɝɥɚɫɧɨɡɚɤɨɧɚɦɬɚɤɢɯɪɟɝɢɨɧɨɜɫɬɪɚɧɩɨɤɭɩɚɬɟɥɸɦɨɝɭɬɛɵɬɶɩɪɟɞɨɫɬɚɜɥɟɧɵɞɨɩɨɥɧɢɬɟɥɶɧɵɟɫɪɟɞɫɬɜɚɩɪɚɜɨɜɨɣɡɚɳɢɬɵ Ʉɫɜɟɞɟɧɢɸɩɨɥɶɡɨɜɚɬɟɥɹɧɚɩɨɫɥɟɞɧɟɣɫɬɪɚɧɢɰɟɛɪɨɲɸɪɵɭɤɚɡɚɧɵɞɚɬɚɜɵɩɭɫɤɚɢɥɢɪɟɞɚɤɰɢɢɢɧɨɦɟɪɪɟɞɚɤɰɢɢɞɚɧɧɵɯ ɢɧɫɬɪɭɤɰɢɣȿɫɥɢɫɭɤɚɡɚɧɧɨɣɞɚɬɵɞɨɩɪɢɦɟɧɟɧɢɹɢɡɞɟɥɢɹɩɪɨɲɥɨɦɟɫɹɰɟɜɬɨɧɟɨɛɯɨɞɢɦɨɨɛɪɚɬɢɬɶɫɹɜɤɨɦɩɚɧɢɸ %DUG3HULSKHUDO9DVFXODU,QFɞɥɹɩɪɨɜɟɪɤɢɧɚɥɢɱɢɹɞɨɩɨɥɧɢɬɟɥɶɧɨɣɢɧɮɨɪɦɚɰɢɢɨɛɢɡɞɟɥɢɢ (51)

Bullet Tip Embout Spitze Punta a proiettile Punta de bala Kogelvormige punt Ponta em forma de bala ǱțȡȠıȤȒȝĮĲȠȢıĳĮȓȡĮȢ Kuglespids Kulspets Kuulamainen kärki Kulespiss .RĔFyZNDVWRĪNRZD Lövedékhegy Kulatá ãSLþNa Mermi Uç ɉɭɥɟɜɢɞɧɵɣɧɚɤɨɧɟɱɧɢɤ 子彈型末稍 탄환 모양 팁

Rod 60 Tige 60 Spitze 60 Asta 60 Varilla 60 Staaf 60 Haste 60 ȇȐȕįȠȢ Skaft 60 Stav 60 Sauva 60 Stang 60 Mandryn 60 60-as rúd Táhlo 60 Çubuk 60 ɋɬɟɪɠɟɧɶ 桿 60 로드 60

Blunt Tip Embout en mousse Stumpfe Spitze Punta Smussata Punta roma Stompe punt Ponta redonda ǹȝȕȜȪȐțȡȠ Stump spids Trubbig spets Tylppä kärki Butt spiss 7ĊSR]DNRĔF]RQDNRĔFyZND Tompa hegy Tupá ãSLþNa Küt Uç Ɂɚɤɪɭɝɥɟɧɧɵɣɧɚɤɨɧɟɱɧɢɤ 鈍性末稍 뭉툭한 팁

Rod 120 Tige 120 Spitze 120 Asta 120 Varilla 120 Staaf 120 Haste 120 ȇȐȕįȠȢ Skaft 120 Stav 120 Sauva 120 Stang 120 Mandryn 120 120-as rúd Táhlo 120 Çubuk 120 ɋɬɟɪɠɟɧɶ 桿 120 로드 120

Straight Rod Tige droite Gerade Stange Asta diritta Varilla recta Rechte staaf Haste direita ǼȣșİȓĮȡȐȕįȠȢ Lige skaft Rak stav Suora sauva Rett stang Mandryn prosty Egyenes rúd Rovné táhlo Düz Çubuk ɉɪɹɦɨɣɫɬɟɪɠɟɧɶ 直桿 직선 로드

Rod 180 Tige 180 Spitze 180 Asta 180 Varilla 180 Staaf 180 Haste 180 ȇȐȕįȠȢ Skaft 180 Stav 180 Sauva 180 Stang 180 Mandryn 180 180-as rúd Táhlo 180 Çubuk 180 ɋɬɟɪɠɟɧɶ 桿 180 로드 180

Manufacturer: Bard Peripheral Vascular, Inc. 1625 West 3rd Street Tempe, AZ 85281 USA TEL: 1-480-894-9515 1-800-321-4254 FAX: 1-480-966-7062 1-800-440-5376 www.bardpv.com

Innovation for Optimal Outcomes TM

Authorised Representative in the European Community Bard Limited Forest House Tilgate Forest Business Park Brighton Road, Crawley West Sussex, RH11 9BP, UK

PK1136700 Rev. 3 08/14

Previous Page Next Page

BARD

Peripheral Vascular Systems

Arteriovenous Sheath Tunneler Set and Sterilization Cassette Information For Use